Novel Drugs Limited
Pharmaceutical company manufacturing and selling medical drugs, chemicals, and formulations since 1994.
1994 | Mylapore Chennai.600 004, Tamil Nadu (India) | Active
Novel Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.20 M
- Company Age 31 Year, 1 Day
- Open Charges ₹ 8.77 Cr
About Novel Drugs
Novel Drugs Limited (NDL) is a Public Limited Indian Non-Government Company incorporated in India on 03 June 1994 and has a history of 31 years. Its registered office is in Mylapore, Chennai.600 004, Tamil Nadu.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹8.77 Cr.
Gnanatilakan Sebastian, Chandra Gnanatilakan, Karunakaran Sebastin, and One other member serve as directors at the Company.
Company Details
- Location Mylapore, Chennai.600 004, Tamil Nadu
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231TN1994PLC027710
- Company No.
027710
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Jun 1994
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Novel Drugs Limited
Explore comprehensive data for Novel Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Novel Drugs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gnanatilakan Sebastian  | Director | 30-Jul-1996 | Current |
| Chandra Gnanatilakan | Director | 14-Aug-2008 | Current |
| Karunakaran Sebastin | Director | 03-Jun-1994 | Current |
| Mary Justine | Director | 14-Aug-2008 | Current |
Financial Performance of Novel Drugs.
Enhance accessibility to Novel Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Novel Drugs?
Unlock access to Novel Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medzone Pharmaceuticals Private LimitedChandra Gnanatilakan is a mutual person
Charges (Loans)
Open Charges
₹8.77 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 8.00 Cr
- The Lakshmi Vilas Bank Ltd. : 0.77 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2005 | State Bank Of India | ₹3.48 Cr | Open |
| 27 Jan 2005 | State Bank Of India | ₹2.41 Cr | Open |
| 18 Dec 2003 | State Bank Of India | ₹1.96 Cr | Open |
| 31 Mar 2000 | The Lakshmi Vilas Bank Ltd. | ₹7.70 M | Open |
| 23 Sep 1996 | State Bank Of India | ₹1.48 M | Open |
How Many Employees Work at Novel Drugs?
Unlock and access historical data on people associated with Novel Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novel Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Novel Drugs
Recent activity within the organization
- Director Appointment
Chandra Gnanatilakan was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 16 years 9 months .
- Director Appointment
Mary Vasundra Justine was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 16 years 9 months .
- Charges
A charge with State Bank Of India amounted to Rs. 3.48 Cr with Charge ID 90321165 was registered on 16 Mar 2005.
- Charges
A charge with State Bank Of India amounted to Rs. 2.41 Cr with Charge ID 90322299 was registered on 27 Jan 2005.
- Charges
A charge with State Bank Of India amounted to Rs. 1.96 Cr with Charge ID 90322291 was registered on 18 Dec 2003.
- Charges
A charge with The Lakshmi Vilas Bank Ltd. amounted to Rs. 0.77 Cr with Charge ID 90321014 was registered on 31 Mar 2000.
Frequently asked questions
What is the Incorporation or founding date of Novel Drugs Limited?
Novel Drugs Limited was incorporated on 03 Jun 1994.
What is authorized share capital and paid-up capital of Novel Drugs Limited?
The authorized share capital of Novel Drugs Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.20 M.
Who are the current board members & directors of Novel Drugs Limited?
Currently 4 directors are associated with Novel Drugs Limited.
- Gnanatilakan Sebastian
- Chandra Gnanatilakan
- Karunakaran Sebastin
- Mary Vasundra Justine
What is the registered address of Novel Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Novel Drugs Limited is No.33 Nainar Road Mylapore, India, Mylapore Chennai.600 004, Tamil Nadu.
What is the corporate identification number (CIN) and company number of Novel Drugs Limited?
The corporate identification number (CIN) of Novel Drugs Limited is U24231TN1994PLC027710 and the company number is 027710 as per Ministry of Corporate Affairs (MCA).
What are the total open charges for Novel Drugs Limited?
As per the financial statements for fiscal Year 0, The total open charges for Novel Drugs Limited amount to ₹ 8.77 Cr.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
SV
Soorya VenkatramaDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India